LIM
TEVA icon

Lingotto Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Lingotto Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685M Sell
20,205,943
-7,564,914
-27% -$252M 14.67% 1
2026
Q1 		$836M Sell
27,770,857
-651,911
-2% -$21M 16.52% 1
2025
Q4 		$887M Sell
28,422,768
-166,022
-0.6% -$4.09M 15.46% 2
2025
Q3 		$577M Buy
28,588,790
+431,872
+2% +$7.59M 10.67% 3
2025
Q2 		$472M Buy
28,156,918
+302,975
+1% +$4.89M 10.03% 3
2025
Q1 		$428M Buy
27,853,943
+661,555
+2% +$11.8M 11.18% 3
2024
Q4 		$599M Buy
27,192,388
+688,862
+3% +$12.5M 16.08% 2
2024
Q3 		$478M Buy
26,503,526
+40,926
+0.2% +$716K 13.77% 2
2024
Q2 		$430M Buy
26,462,600
+38,065
+0.1% +$586K 14.45% 2
2024
Q1 		$373M Sell
26,424,535
-8,033,121
-23% -$101M 15.61% 1
2023
Q4 		$360M Buy
34,457,656
+607,800
+2% +$5.67M 17.32% 1
2023
Q3 		$345M Buy
33,849,856
+9,636,595
+40% +$89.7M 18.51% 1
2023
Q2 		$182M Buy
24,213,261
+7,121,351
+42% +$57.7M 11.78% 2
2023
Q1 		$151M Buy
17,091,910
+2,083,521
+14% +$20.6M 10.83% 2
2022
Q4 		$93.9M Buy
15,008,389
+3,486,202
+30% +$30.4M 7.05% 9
2022
Q3 		$93M Buy
+11,522,187
New +$102M 8.56% 6
2022
Q1 		– Sell
-15,008,389
Closed -$93.9M – 20
2021
Q4 		$93.9M Buy
+15,008,389
New +$135M 7.05% 9

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lingotto Investment Management's TEVA Position: Q2 2026 in Review

Lingotto Investment Management reduced its Teva Pharmaceuticals (TEVA) stake by 27% in Q2 2026, selling an estimated $252M and leaving 20,205,943 shares worth $685M. The position accounts for 14.67% of the portfolio, ranked #1.

Lingotto Investment Management first reported a position in TEVA in Q4 2021 and has held it in 17 quarters since. The position peaked at $887M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Lingotto Investment Management held 20,205,943 shares of Teva Pharmaceuticals worth $685M as of Q2 2026.
  • Lingotto Investment Management sold 7,564,914 Teva Pharmaceuticals shares in Q2 2026, an estimated $252M.
  • Teva Pharmaceuticals made up 14.67% of Lingotto Investment Management's portfolio in Q2 2026, its #1 holding.
  • Lingotto Investment Management first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • Lingotto Investment Management's Teva Pharmaceuticals position peaked at $887M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Lingotto Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.